Nisa Investment Advisors
TXMD icon

Nisa Investment Advisors’s TherapeuticsMD TXMD Stock Holding History

Nisa Investment Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-759
Closed -$45 – 2332
2021
Q2 		$45 Buy
+759
New +$46K ﹤0.01% 1969
2020
Q4 		– Sell
-117
Closed -$9K – 2355
2020
Q3 		$9K Sell
117
-22
-16% -$1.75K ﹤0.01% 2135
2020
Q2 		$9K Sell
139
-544
-80% -$31.7K ﹤0.01% 1944
2020
Q1 		$36K Hold
683
– – ﹤0.01% 1601
2019
Q4 		$83K Hold
683
– – ﹤0.01% 1466
2019
Q3 		$124K Buy
683
+666
+3,918% +$93.9K ﹤0.01% 1419
2019
Q2 		$2K Hold
17
– – ﹤0.01% 1981
2019
Q1 		$4K Hold
17
– – ﹤0.01% 1948
2018
Q4 		$3K Hold
17
– – ﹤0.01% 1881
2018
Q3 		$5K Hold
17
– – ﹤0.01% 1874
2018
Q2 		$5K Hold
17
– – ﹤0.01% 1836
2018
Q1 		$4K Buy
+17
New +$4.77K ﹤0.01% 1818
2017
Q2 		– Sell
-21
Closed -$8K – 1864
2017
Q1 		$8K Sell
21
-219
-91% -$67.8K ﹤0.01% 1735
2016
Q4 		$69K Buy
+240
New +$74.4K ﹤0.01% 1390

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nisa Investment Advisors's TXMD Position: Q3 2021 in Review

Nisa Investment Advisors sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 759 shares — an estimated $45 sold.

Nisa Investment Advisors first reported a position in TXMD in Q4 2016 and held it in 14 quarters. The position peaked at $124K in Q3 2019. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • Nisa Investment Advisors reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 759 TherapeuticsMD shares in Q3 2021, an estimated $45.
  • Nisa Investment Advisors first reported a position in TherapeuticsMD in Q4 2016 and held it in 14 quarters.
  • Nisa Investment Advisors's TherapeuticsMD position peaked at $124K in Q3 2019.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Nisa Investment Advisors's 13F filing for Q3 2021, filed 18 Oct 2021.